de Castro, D.G.; Pellizzon, A.C.A.; Braun, A.C.; Chen, M.J.; Silva, M.L.G.; Fogaroli, R.C.; Gondim, G.R.M.; Ramos, H.; Neto, E.S.; Abrahão, C.H.;
et al. Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control. Cancers 2022, 14, 3101.
https://doi.org/10.3390/cancers14133101
AMA Style
de Castro DG, Pellizzon ACA, Braun AC, Chen MJ, Silva MLG, Fogaroli RC, Gondim GRM, Ramos H, Neto ES, Abrahão CH,
et al. Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control. Cancers. 2022; 14(13):3101.
https://doi.org/10.3390/cancers14133101
Chicago/Turabian Style
de Castro, Douglas Guedes, Antônio Cássio Assis Pellizzon, Alexcia Camila Braun, Michael Jenwei Chen, Maria LetÃcia Gobo Silva, Ricardo Cesar Fogaroli, Guilherme Rocha Melo Gondim, Henderson Ramos, Elson Santos Neto, Carolina Humeres Abrahão,
and et al. 2022. "Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control" Cancers 14, no. 13: 3101.
https://doi.org/10.3390/cancers14133101
APA Style
de Castro, D. G., Pellizzon, A. C. A., Braun, A. C., Chen, M. J., Silva, M. L. G., Fogaroli, R. C., Gondim, G. R. M., Ramos, H., Neto, E. S., Abrahão, C. H., Yu, L. S., Abdallah, E. A., Calsavara, V. F., & Chinen, L. T. D.
(2022). Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control. Cancers, 14(13), 3101.
https://doi.org/10.3390/cancers14133101
